Clinical Trials Browser

Phase 3 × Interventional × SHR-1701 × Clear all

NCT05179239 2025-04-15

A Study of SHR-1701 Plus Platinum-containing Chemotherapy With or Without BP102 (Bevacizumab) as First-line Treatment in Cervical Cancer

Phase 3 Terminated

Uterine Cervical Neoplasms

NCT05132413 2021-11-24

A Study of SHR-1701 Plus Bevacizumab and Chemotherapy in Non-Small-Cell-Lung-Cancer

Phase 3 Unknown

Advanced or Metastatic Non-squamous Non-small-cell Lung Cancer